Table 3.
Relationship between gender and etiology in patients with Budd-Chiari syndrome (n = 94)
| Etiology | Gender n (%) | χ² | P value | Sig | ||
| Male | Female | |||||
| PC deficiency | + | 1 (2.90) | 3 (5.20) | 1 | NS | |
| PS deficiency | + | 1 (2.90) | 0 (0.00) | 0.38 | NS | |
| AT III deficiency | + | 2 (5.70) | 2 (3.40) | 0.63 | NS | |
| FVLM | Homozygous | 5 (20.80) | 5 (12.50) | 1.77 | 0.18 | NS |
| Heterozygous | 6 (25.00) | 18 (45.00) | ||||
| PGM | Homozygous | 0 (0.00) | 1 (2.60) | 1.54 | 0.21 | NS |
| Heterozygous | 0 (0.00) | 2 (5.10) | ||||
| MTHFR | Homozygous | 6 (28.60) | 2 (5.10) | 8.41 | 0.01 | HS |
| Heterozygous | 9 (42.90) | 14 (35.90) | ||||
| JAK2 (MPD) | + | 6 (28.60) | 12 (29.30) | 0.003 | 0.95 | NS |
| Primary APA | + | 5 (13.90) | 11 (19.00) | 0.4 | 0.52 | NS |
| Secondary APA | + | 1 (2.80) | 10 (17.20) | 0.05 S | ||
| Behçet’s disease | + | 11 (30.60) | 1 (1.70) | < 0.001 VHS | ||
| PNH | + | 1 (2.80) | 1 (1.70) | 1 NS | ||
Sig: Significance; NS: Not significant; S: Significant; HS: Highly significant; VHS: Very highly significant; PC: Protein C; PS: Protein S; AT: Antithrombin; FVLM: Factor V Leiden mutation; PGM: Prothrombin gene mutation; MTHFR: Methylene tetrahydrofolate reductase; JAK2: Janus tyrosine kinase-2; MPD: Myeloproliferative disorder; APA: Antiphospholipid antibody syndrome; PNH: Paroxysmal nocturnal hemoglobinuria.